ITSN2
Intersectin-2
Also known as: ITSN2_HUMAN, KIAA1256, PRO2015, SH3D1B, SH3P18, SWA, SWAP
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9NZM3
- Gene
- ITSN2
- Ensembl
- ENSG00000198399
- Chromosome
- 2
- Canonical length
- 1697 aa
- Protein class
- Predicted intracellular proteins
- Subcellular location
- Vesicles,Plasma membrane
OverviewNCBI Gene
This gene encodes a cytoplasmic protein which contains SH3 domains. This protein is a member of a family of proteins involved in clathrin-mediated endocytosis. Intersectin 2 is thought to regulate the formation of clathrin-coated vesicles and also may function in the induction of T cell antigen receptor (TCR) endocytosis. [provided by RefSeq, Jan 2017]
Canonical amino-acid sequenceUniProt
1697 residues, UniProt reviewed canonical sequence.
>Q9NZM3|ITSN2
1 MMAQFPTAMN GGPNMWAITS EERTKHDRQF DNLKPSGGYI TGDQARNFFL QSGLPAPVLA
61 EIWALSDLNK DGKMDQQEFS IAMKLIKLKL QGQQLPVVLP PIMKQPPMFS PLISARFGMG
121 SMPNLSIPQP LPPAAPITSL SSATSGTNLP PLMMPTPLVP SVSTSSLPNG TASLIQPLPI
181 PYSSSTLPHG SSYSLMMGGF GGASIQKAQS LIDLGSSSST SSTASLSGNS PKTGTSEWAV
241 PQPTRLKYRQ KFNTLDKSMS GYLSGFQARN ALLQSNLSQT QLATIWTLAD VDGDGQLKAE
301 EFILAMHLTD MAKAGQPLPL TLPPELVPPS FRGGKQIDSI NGTLPSYQKM QEEEPQKKLP
361 VTFEDKRKAN YERGNMELEK RRQALMEQQQ REAERKAQKE KEEWERKQRE LQEQEWKKQL
421 ELEKRLEKQR ELERQREEER RKDIERREAA KQELERQRRL EWERIRRQEL LNQKNREQEE
481 IVRLNSKKKN LHLELEALNG KHQQISGRLQ DVRLKKQTQK TELEVLDKQC DLEIMEIKQL
541 QQELQEYQNK LIYLVPEKQL LNERIKNMQF SNTPDSGVSL LHKKSLEKEE LCQRLKEQLD
601 ALEKETASKL SEMDSFNNQL KCGNMDDSVL QCLLSLLSCL NNLFLLLKEL RETYNTQQLA
661 LEQLYKIKRD KLKEIERKRL ELMQKKKLED EAARKAKQGK ENLWKENLRK EEEEKQKRLQ
721 EEKTQEKIQE EERKAEEKQR KDKDTLKAEE KKRETASVLV NYRALYPFEA RNHDEMSFNS
781 GDIIQVDEKT VGEPGWLYGS FQGNFGWFPC NYVEKMPSSE NEKAVSPKKA LLPPTVSLSA
841 TSTSSEPLSS NQPASVTDYQ NVSFSNLTVN TSWQKKSAFT RTVSPGSVSP IHGQGQVVEN
901 LKAQALCSWT AKKDNHLNFS KHDIITVLEQ QENWWFGEVH GGRGWFPKSY VKIIPGSEVK
961 REEPEALYAA VNKKPTSAAY SVGEEYIALY PYSSVEPGDL TFTEGEEILV TQKDGEWWTG
1021 SIGDRSGIFP SNYVKPKDQE SFGSASKSGA SNKKPEIAQV TSAYVASGSE QLSLAPGQLI
1081 LILKKNTSGW WQGELQARGK KRQKGWFPAS HVKLLGPSSE RATPAFHPVC QVIAMYDYAA
1141 NNEDELSFSK GQLINVMNKD DPDWWQGEIN GVTGLFPSNY VKMTTDSDPS QQWCADLQTL
1201 DTMQPIERKR QGYIHELIQT EERYMADLQL VVEVFQKRMA ESGFLTEGEM ALIFVNWKEL
1261 IMSNTKLLKA LRVRKKTGGE KMPVQMIGDI LAAELSHMQA YIRFCSCQLN GAALLQQKTD
1321 EDTDFKEFLK KLASDPRCKG MPLSSFLLKP MQRITRYPLL IRSILENTPE SHADHSSLKL
1381 ALERAEELCS QVNEGVREKE NSDRLEWIQA HVQCEGLAEQ LIFNSLTNCL GPRKLLHSGK
1441 LYKTKSNKEL HGFLFNDFLL LTYMVKQFAV SSGSEKLFSS KSNAQFKMYK TPIFLNEVLV
1501 KLPTDPSSDE PVFHISHIDR VYTLRTDNIN ERTAWVQKIK AASEQYIDTE KKKREKAYQA
1561 RSQKTSGIGR LMVHVIEATE LKACKPNGKS NPYCEISMGS QSYTTRTIQD TLNPKWNFNC
1621 QFFIKDLYQD VLCLTLFDRD QFSPDDFLGR TEIPVAKIRT EQESKGPMTR RLLLHEVPTG
1681 EVWVRFDLQL FEQKTLLLocalizationUniProt · AlphaFold · HPA
Whether an antibody against ITSN2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.42
- Highest tissue expression
- 69 nTPM
Expression across tissuesHPA
Tissue
- bone marrow: 69 nTPM
- pancreas: 63 nTPM
- lymph node: 50 nTPM
- tonsil: 48 nTPM
- thyroid gland: 47 nTPM
- spleen: 41 nTPM
Single-cell type
- esophageal apical cells: 1,103 nCPM
- neutrophils: 747 nCPM
- b-cells: 481 nCPM
- neutrophil progenitors: 440 nCPM
- urothelial cells: 397 nCPM
- cdc: 377 nCPM
Immune cell
- neutrophil: 113 nTPM
- naive B-cell: 73 nTPM
- basophil: 70 nTPM
- memory B-cell: 69 nTPM
- non-classical monocyte: 60 nTPM
- eosinophil: 56 nTPM
Brain region
- choroid plexus: 63 nTPM
- thalamus: 60 nTPM
- white matter: 57 nTPM
- midbrain: 53 nTPM
- medulla oblongata: 52 nTPM
- cerebral cortex: 51 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.49
- gnomAD pLI
- 0
- gnomAD missense Z
- 1.12
- DepMap mean gene effect
- -0.08
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- cell differentiation
- clathrin-dependent synaptic vesicle endocytosis
- endosomal transport
- positive regulation of dendrite extension
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- C2 domain
- Dbl homology domain
- EH domain
- SH3 domain
- Pleckstrin homology domain
- EF-hand domain
- EF-hand domain pair
- PH-like domain superfamily
- EF-Hand 1, calcium-binding site
- C2 domain superfamily
- Dbl homology (DH) domain superfamily
- SH3-like domain superfamily
- Endocytic & GEF Adapter
- SH3 domain
- C2 domain
- RhoGEF domain
- Variant SH3 domain
- EH domain
- Variant SH3 domain
- Pleckstrin homology domain
- Intersectin-2, first SH3 domain
- Intersectin-2, second SH3 domain
- Intersectin-2, third SH3 domain
- Intersectin-2, fourth SH3 domain
- Intersectin-2, fifth SH3 domain
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of ITSN2 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads ITSN2 as an antibody target. Whether an autoantibody or antibody against ITSN2 could matter depends on whether native ITSN2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
ITSN2 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label ITSN2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...